Trial Profile

Safety of SEVENFACT for the Treatment of Bleeding Events in Patients With Hemophilia A or B With Inhibitors

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 29 Mar 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Recombinant factor VIIa (Primary) ; Emicizumab
Indications Haemophilia A; Haemophilia B
Focus Adverse reactions
Acronyms ATHN 16

Most Recent Events

18 Nov 2024 Planned End Date changed from 1 Jun 2025 to 31 Mar 2027.
18 Nov 2024 Planned primary completion date changed from 30 Nov 2024 to 30 Sep 2026.
01 Jun 2023 Planned primary completion date changed from 31 Oct 2023 to 30 Nov 2024.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com